Literature DB >> 28716705

Pathobiology of biliary epithelia.

Angela C Cheung1, Maria J Lorenzo Pisarello1, Nicholas F LaRusso2.   

Abstract

Cholangiocytes are epithelial cells that line the intra- and extrahepatic biliary tree. They serve predominantly to mediate the content of luminal biliary fluid, which is controlled via numerous signaling pathways influenced by endogenous (e.g., bile acids, nucleotides, hormones, neurotransmitters) and exogenous (e.g., microbes/microbial products, drugs etc.) molecules. When injured, cholangiocytes undergo apoptosis/lysis, repair and proliferation. They also become senescent, a form of cell cycle arrest, which may prevent propagation of injury and/or malignant transformation. Senescent cholangiocytes can undergo further transformation to a senescence-associated secretory phenotype (SASP), where they begin secreting pro-inflammatory and pro-fibrotic signals that may contribute to disease initiation and progression. These and other concepts related to cholangiocyte pathobiology will be reviewed herein. This article is part of a Special Issue entitled: Cholangiocytes in Health and Disease edited by Jesus Banales, Marco Marzioni, Nicholas LaRusso and Peter Jansen.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Apoptosis; Bile; Cholangiocytes; Cholangiopathies; Proliferation; Senescence

Mesh:

Substances:

Year:  2017        PMID: 28716705      PMCID: PMC5777905          DOI: 10.1016/j.bbadis.2017.06.024

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  170 in total

1.  Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells.

Authors:  A Benedetti; A Di Sario; L Marucci; G Svegliati-Baroni; C D Schteingart; H T Ton-Nu; A F Hofmann
Journal:  Am J Physiol       Date:  1997-06

2.  Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.

Authors:  Luca Fabris; Massimiliano Cadamuro; Romina Fiorotto; Tania Roskams; Carlo Spirlì; Saida Melero; Aurelio Sonzogni; Ruth E Joplin; Lajos Okolicsanyi; Mario Strazzabosco
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

3.  Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors.

Authors:  Anatoliy I Masyuk; Sergio A Gradilone; Jesus M Banales; Bing Q Huang; Tatyana V Masyuk; Seung-Ok Lee; Patrick L Splinter; Angela J Stroope; Nicholas F Larusso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-07       Impact factor: 4.052

Review 4.  Physiology of cholangiocytes.

Authors:  James H Tabibian; Anatoliy I Masyuk; Tetyana V Masyuk; Steven P O'Hara; Nicholas F LaRusso
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

5.  After damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes.

Authors:  Romina Mancinelli; Antonio Franchitto; Eugenio Gaudio; Paolo Onori; Shannon Glaser; Heather Francis; Julie Venter; Sharon Demorrow; Guido Carpino; Shelley Kopriva; Mellanie White; Giammarco Fava; Domenico Alvaro; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2010-02-25       Impact factor: 4.307

Review 6.  Perspective: TGR5 (Gpbar-1) in liver physiology and disease.

Authors:  Verena Keitel; Dieter Häussinger
Journal:  Clin Res Hepatol Gastroenterol       Date:  2012-04-18       Impact factor: 2.947

7.  HDAC6 inhibition restores ciliary expression and decreases tumor growth.

Authors:  Sergio A Gradilone; Brynn N Radtke; Pamela S Bogert; Bing Q Huang; Gabriella B Gajdos; Nicholas F LaRusso
Journal:  Cancer Res       Date:  2013-01-31       Impact factor: 12.701

Review 8.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 9.  The enteric microbiome in hepatobiliary health and disease.

Authors:  James H Tabibian; Cyril Varghese; Nicholas F LaRusso; Steven P O'Hara
Journal:  Liver Int       Date:  2015-12-12       Impact factor: 5.828

10.  Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity.

Authors:  Shannon Glaser; Domenico Alvaro; Tania Roskams; Jo Lynne Phinizy; George Stoica; Heather Francis; Yoshiyuki Ueno; Barbara Barbaro; Marco Marzioni; Jeremy Mauldin; Sobia Rashid; Maria Grazia Mancino; Gene LeSage; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-12-27       Impact factor: 4.052

View more
  13 in total

1.  Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia.

Authors:  Yongtao Xiao; Runping Liu; Xiaojiaoyang Li; Emily C Gurley; Phillip B Hylemon; Ying Lu; Huiping Zhou; Wei Cai
Journal:  Hepatology       Date:  2019-06-21       Impact factor: 17.425

Review 2.  Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.

Authors:  Christy E Trussoni; Steven P O'Hara; Nicholas F LaRusso
Journal:  Semin Immunopathol       Date:  2022-02-17       Impact factor: 11.759

3.  The heterogeneity of the biliary tree.

Authors:  Iris E M de Jong; Marius C van den Heuvel; Rebecca G Wells; Robert J Porte
Journal:  J Hepatol       Date:  2021-08-20       Impact factor: 25.083

4.  Rotavirus Reassortant-Induced Murine Model of Liver Fibrosis Parallels Human Biliary Atresia.

Authors:  Sujit K Mohanty; Inna Lobeck; Bryan Donnelly; Phylicia Dupree; Ashley Walther; Sarah Mowery; Abigail Coots; Alexander Bondoc; Rachel M Sheridan; Holly M Poling; Haley Temple; Monica McNeal; Karol Sestak; Ruchi Bansal; Greg Tiao
Journal:  Hepatology       Date:  2020-02-11       Impact factor: 17.425

Review 5.  Cholangiopathies - Towards a molecular understanding.

Authors:  Paul K H Tam; Rachel S Yiu; Urban Lendahl; Emma R Andersson
Journal:  EBioMedicine       Date:  2018-09-17       Impact factor: 8.143

6.  Biophysical Control of Bile Duct Epithelial Morphogenesis in Natural and Synthetic Scaffolds.

Authors:  Anette Funfak; Latifa Bouzhir; Emilie Gontran; Nicolas Minier; Pascale Dupuis-Williams; Samy Gobaa
Journal:  Front Bioeng Biotechnol       Date:  2019-12-13

7.  Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells.

Authors:  L Valestrand; N L Berntsen; F Zheng; E Schrumpf; S H Hansen; T H Karlsen; R S Blumberg; J R Hov; X Jiang; E Melum
Journal:  Clin Exp Immunol       Date:  2020-11-16       Impact factor: 4.330

8.  Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis.

Authors:  Takahiro Nishio; Yukinori Koyama; Xiao Liu; Sara B Rosenthal; Gen Yamamoto; Hiroaki Fuji; Jacopo Baglieri; Na Li; Laura N Brenner; Keiko Iwaisako; Kojiro Taura; James S Hagood; Nicholas F LaRusso; Tapan K Bera; Ira Pastan; David A Brenner; Tatiana Kisseleva
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-20       Impact factor: 12.779

9.  Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury.

Authors:  Adrien Guillot; Lucia Guerri; Dechun Feng; Seung-Jin Kim; Yeni Ait Ahmed; Janos Paloczi; Yong He; Kornel Schuebel; Shen Dai; Fengming Liu; Pal Pacher; Tatiana Kisseleva; Xuebin Qin; David Goldman; Frank Tacke; Bin Gao
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 19.456

Review 10.  Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies.

Authors:  Debora Maria Giordano; Claudio Pinto; Luca Maroni; Antonio Benedetti; Marco Marzioni
Journal:  Int J Mol Sci       Date:  2018-10-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.